Lava Therapeutics: Funding, Investors & Team (Oct 2026)
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of hematological and solid cancers. Its platform creates and develops next-generation γδ T cell engaging bispecific antibodies for the treatment of cancer as well as develop potent, safe, and cost-effective biopharmaceuticals that arm the immune system to recognize and destroy tumor cells that enable doctors to safely channel the immune system's response towards tumors.
Lava Therapeutics has raised $83.0M across 1 funding round on record, the most recent an undisclosed round of $83.0M announced in Sep 2020.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lava Therapeutics Company Profile and Key Stats
Latest funding round on record: Sep 2020.
Lava Therapeutics Funding Rounds
Lava Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Lava Therapeutics Funding Compared to Other Biotechnology Startups
Lava Therapeutics' latest round of $83.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lava Therapeutics in Biotechnology and Utrecht
Companies Similar to Lava Therapeutics
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
Lava Therapeutics Funding FAQs
What does Lava Therapeutics do?
Lava Therapeutics is a developer of a bispecific antibody platform used to engage gamma-delta T cells for the treatment of hematological and solid cancers. Its platform creates and develops next-generation γδ T cell engaging bispecific antibodies for the treatment of cancer as well as develop potent, safe, and cost-effective biopharmaceuticals that arm the immune system to recognize and destroy tumor cells that enable doctors to safely channel the immune system's response towards tumors.
How much funding has Lava Therapeutics raised?
Lava Therapeutics has raised $83.0M across 1 round on record. The most recent is an undisclosed round of $83.0M announced in Sep 2020.
When did Lava Therapeutics last raise funding?
Lava Therapeutics' most recent funding round on record is an undisclosed round of $83.0M, announced in Sep 2020.
Who is the CEO of Lava Therapeutics?
Stephen Hurly is listed as CEO at Lava Therapeutics.
Where is Lava Therapeutics headquartered?
Lava Therapeutics is based in Utrecht, Netherlands.
How many employees does Lava Therapeutics have?
Lava Therapeutics is in the 51-100 employee band.
How does Lava Therapeutics' funding compare to other Biotechnology startups?
Lava Therapeutics' latest round of $83.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Lava Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lava Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.